Royal Bank of Canada
ISEE

Royal Bank of Canada’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Royal Bank of Canada’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,105
Closed -$555K – 7954
2023
Q2 		$555K Sell
14,105
-2,823
-17% -$99.6K ﹤0.01% 3869
2023
Q1 		$412K Sell
16,928
-9,766
-37% -$214K ﹤0.01% 4033
2022
Q4 		$573K Buy
26,694
+17,902
+204% +$382K ﹤0.01% 3992
2022
Q3 		$158K Buy
8,792
+5,620
+177% +$73.8K ﹤0.01% 4959
2022
Q2 		$30K Sell
3,172
-6,412
-67% -$80.5K ﹤0.01% 5941
2022
Q1 		$161K Sell
9,584
-16,404
-63% -$242K ﹤0.01% 5281
2021
Q4 		$435K Buy
25,988
+12,398
+91% +$203K ﹤0.01% 4600
2021
Q3 		$221K Buy
13,590
+4,434
+48% +$48.3K ﹤0.01% 5081
2021
Q2 		$58K Buy
9,156
+1,832
+25% +$11.8K ﹤0.01% 5944
2021
Q1 		$46K Buy
7,324
+984
+16% +$5.97K ﹤0.01% 5945
2020
Q4 		$44K Buy
6,340
+3,785
+148% +$24.2K ﹤0.01% 5720
2020
Q3 		$14K Hold
2,555
– – ﹤0.01% 5830
2020
Q2 		$13K Hold
2,555
– – ﹤0.01% 5753
2020
Q1 		$9K Hold
2,555
– – ﹤0.01% 5870
2019
Q4 		$22K Sell
2,555
-883
-26% -$3.15K ﹤0.01% 5822
2019
Q3 		$4K Buy
3,438
+733
+27% +$853 ﹤0.01% 6139
2019
Q2 		$4K Hold
2,705
– – ﹤0.01% 6424
2019
Q1 		$4K Buy
2,705
+196
+8% +$274 ﹤0.01% 6375
2018
Q4 		$3K Buy
2,509
+216
+9% +$419 ﹤0.01% 6385
2018
Q3 		$5K Buy
2,293
+478
+26% +$1.19K ﹤0.01% 6297
2018
Q2 		$5K Hold
1,815
– – ﹤0.01% 6061
2018
Q1 		$5K Sell
1,815
-82
-4% -$238 ﹤0.01% 5947
2017
Q4 		$6K Buy
1,897
+27
+1% +$76 ﹤0.01% 6044
2017
Q3 		$5K Sell
1,870
-300
-14% -$810 ﹤0.01% 6431
2017
Q2 		$6K Sell
2,170
-1,146
-35% -$3.12K ﹤0.01% 5998
2017
Q1 		$12K Sell
3,316
-14,497
-81% -$61.3K ﹤0.01% 5885
2016
Q4 		$86K Sell
17,813
-330
-2% -$9.8K ﹤0.01% 4955
2016
Q3 		$837K Sell
18,143
-4,033
-18% -$227K ﹤0.01% 3256
2016
Q2 		$1.13M Buy
22,176
+11,531
+108% +$573K ﹤0.01% 3008
2016
Q1 		$449K Buy
10,645
+4,158
+64% +$212K ﹤0.01% 3734
2015
Q4 		$510K Sell
6,487
-9,552
-60% -$552K ﹤0.01% 3758
2015
Q3 		$650K Buy
16,039
+1,039
+7% +$55K ﹤0.01% 3250
2015
Q2 		$781K Sell
15,000
-700
-4% -$34.8K ﹤0.01% 3141
2015
Q1 		$731K Sell
15,700
-17,515
-53% -$909K ﹤0.01% 3152
2014
Q4 		$1.49M Buy
33,215
+7,528
+29% +$316K ﹤0.01% 2578
2014
Q3 		$1M Buy
25,687
+9,987
+64% +$392K ﹤0.01% 2847
2014
Q2 		$664K Buy
15,700
+2,500
+19% +$91.7K ﹤0.01% 3179
2014
Q1 		$471K Buy
13,200
+4,800
+57% +$162K ﹤0.01% 3392
2013
Q4 		$271K Buy
+8,400
New +$249K ﹤0.01% 3913

Royal Bank of Canada's ISEE Position: Q3 2023 in Review

Royal Bank of Canada sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 14,105 shares — an estimated $555K sold.

Royal Bank of Canada first reported a position in ISEE in Q4 2013 and held it in 39 quarters. The position peaked at $1.49M in Q4 2014. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Royal Bank of Canada reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 14,105 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $555K.
  • Royal Bank of Canada first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 39 quarters.
  • Royal Bank of Canada's IVERIC bio, Inc. Common Stock position peaked at $1.49M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.